Gregory Bailey, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 66,626 shares at $79.88 ($5.3M) on 2020-10-22, disclosed to the SEC on 2020-10-23.
Open-market sale of $5.3M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.41 | 21,466 | $1.7M | 32.3% |
| 2 | $79.41 | 21,466 | $1.7M | 32.3% |
| 3 | $79.88 | 3,100 | $248K | 4.7% |
| 4 | $78.89 | 10,191 | $804K | 15.2% |
| 5 | $78.89 | 10,191 | $804K | 15.2% |
| 6 | $79.94 | 212 |
| $17K |
| 0.3% |
| Total | $79.27 avg | 66,626 | $5.3M | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |